Description
Armadin (Mexidol) Coated Tablets 125 mg. #30
Armadin (Mexidol) is a medication commonly prescribed for various conditions related to the central nervous system. The active ingredient in Armadin is Mexidol, which is known for its antioxidant and neuroprotective properties. This medication is available in the form of coated tablets with a dosage strength of 125 mg. per tablet, and each package contains 30 tablets.
Indications
Armadin (Mexidol) is indicated for the treatment of a range of conditions affecting the central nervous system. Some common indications for this medication include:
- Ischemic stroke
- Traumatic brain injury
- Chronic cerebrovascular insufficiency
- Neurotic disorders
- Anxiety and stress-related disorders
- Alcohol withdrawal syndrome
Mechanism of Action
Mexidol, the active ingredient in Armadin, exerts its therapeutic effects through several mechanisms, including its antioxidant, anti-inflammatory, and neuroprotective properties. Mexidol helps to reduce oxidative stress in the brain, improve blood flow, and enhance the brain’s resistance to hypoxia and ischemia. These actions contribute to Mexidol’s ability to protect nerve cells from damage and promote their recovery.
Dosage and Administration
Armadin (Mexidol) coated tablets are typically taken orally with water. The recommended dosage for adults is 125 mg. (1 tablet) three times a day. The tablets should be swallowed whole and not crushed or chewed. It is important to follow the dosage instructions provided by your healthcare provider to ensure the medication’s effectiveness.
Contraindications
Armadin (Mexidol) is contraindicated in individuals with known hypersensitivity to Mexidol or any of the tablet’s components. Additionally, this medication should not be used in patients with severe liver or kidney disease without medical supervision. It is important to consult with a healthcare provider before starting treatment with Armadin to determine if it is safe and appropriate for you.
Adverse Reactions
Like all medications, Armadin (Mexidol) may cause some side effects in certain individuals. Common adverse reactions associated with Mexidol therapy include:
- Gastrointestinal upset (nausea, vomiting, diarrhea)
- Headache
- Dizziness
- Allergic reactions (rash, itching)
If you experience any severe or persistent side effects while taking Armadin, it is important to seek medical attention promptly.
Precautions
Before using Armadin (Mexidol), inform your healthcare provider about any underlying medical conditions you have, especially liver or kidney disease. It is also important to disclose any medications, supplements, or herbal products you are currently taking to avoid potential drug interactions. Mexidol may potentiate the effects of certain sedatives and anticoagulants, so caution should be exercised when co-administering these medications.
Storage
Armadin (Mexidol) coated tablets should be stored at room temperature (between 15-30°C) in a dry place away from direct sunlight and moisture. Keep the medication out of reach of children and pets. Do not use Armadin past its expiration date, and dispose of any unused or expired tablets properly according to local regulations.
Conclusion
Armadin (Mexidol) coated tablets 125 mg. are a valuable medication used in the management of various central nervous system disorders. Mexidol’s antioxidant and neuroprotective properties make it an effective treatment option for conditions such as ischemic stroke, traumatic brain injury, and neurotic disorders. By following the prescribed dosage and precautions, patients can benefit from the therapeutic effects of Armadin while minimizing the risk of adverse reactions.
It is essential to consult with a healthcare provider before starting treatment with Armadin to ensure that this medication is suitable for your individual needs and to receive personalized dosing instructions. By understanding the indications, mechanism of action, dosage, contraindications, and precautions associated with Armadin, patients can make informed decisions about their treatment and optimize the therapeutic outcomes of Mexidol therapy.
